No single medical condition automatically rules you out for a liver transplant in every situation. Transplant centers evaluate candidates across medical, surgical, psychological, and behavioral dimensions, and what counts as a firm “no” at one hospital may be a manageable obstacle at another. That said, certain conditions consistently raise red flags or serve as absolute contraindications at most programs: uncontrolled cancer outside the liver, severe heart or lung disease, active untreated infection, critical organ failure beyond a point of no return, and active substance use disorders are among the most common reasons people are turned down. The picture is more nuanced than a simple checklist, though, and the boundaries keep shifting as transplant medicine evolves.
Cancer History and the Milan Criteria
A history of cancer outside the liver is one of the most widely recognized contraindications. If you have had an extrahepatic malignancy, transplant teams require that you completed definitive treatment and remained tumor-free for a sufficient period before they will consider listing you.1Cancer Research. Abstract CT207: A prospective observational registry study on transplantation of liver outcomes in patients with a history of cancer within the past five years The required waiting period depends on the type of cancer, its stage at diagnosis, and the center’s own policies. Many programs require two to five tumor-free years, though low-recurrence cancers sometimes have shorter wait times.
When the cancer is in the liver itself, the rules get more specific. For hepatocellular carcinoma (HCC), the most common primary liver cancer, eligibility has been governed for over two decades by the Milan criteria: a single tumor no larger than 5 cm, or up to three tumors each no larger than 3 cm, with no vascular invasion or spread beyond the liver.2PubMed Central. Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria These thresholds were developed to select patients with a genuinely good chance of long-term survival after transplant, and they remain the international benchmark.3PubMed Central. Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive Review
The trouble is that the Milan criteria are arguably too strict. Cumulative experience has shown that some patients whose tumors fall slightly outside these boundaries can still do well after transplant. This has led to expanded criteria at various centers around the world, and tumors that initially exceed Milan limits can sometimes be shrunk with locoregional therapy such as ablation or chemoembolization, a process called downstaging.2PubMed Central. Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria If downstaging brings the tumor burden within acceptable limits and the response is sustained, you can become eligible again. So a cancer diagnosis is not always a permanent disqualifier; it depends on the type, the response to treatment, and how long the response lasts.
Severe Heart and Lung Disease
Liver transplant surgery is a major operation that places enormous stress on the cardiovascular system. If your heart or lungs cannot handle that stress, the transplant itself could kill you. Severe portopulmonary hypertension, a type of high blood pressure in the lungs that develops as a complication of liver disease, is considered an absolute contraindication to transplant at most centers.4American Journal of Transplantation. Successful Liver Transplantation Following Medical Management of Portopulmonary Hypertension: A Single-Center Series The danger is that when blood flow through the new liver is restored during surgery, the right side of the heart can fail catastrophically if pulmonary pressures are too high.
Milder forms of portopulmonary hypertension, however, can sometimes be managed medically before surgery. If treatment brings pulmonary pressures down to an acceptable range, a patient who was initially ruled out may become a candidate. Similarly, advanced coronary artery disease, severe heart failure, or significant valvular heart disease can each disqualify you, but only if the cardiac condition cannot be corrected or stabilized beforehand. The transplant team will typically order a thorough cardiac workup, including echocardiography and sometimes cardiac catheterization, to assess whether your heart can tolerate the procedure.
When You Are Too Sick to Transplant
This is one of the cruelest paradoxes of liver transplantation: the sicker you are, the more desperately you need a new liver, but at a certain point you become too sick for surgery to help. Transplant teams call this the “futility” threshold, the point at which multi-organ failure is so severe that a new liver would not reverse the damage already done to other organ systems.
An international panel of experts reached consensus on specific markers of futility: a severely impaired ratio of oxygen in the blood to oxygen being delivered (below a specific threshold), a very high dose of vasopressor medication needed to maintain blood pressure, and an extremely elevated serum lactate level indicating severe metabolic collapse.5PubMed. When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts These thresholds aim to identify patients in whom respiratory, circulatory, and metabolic failure have progressed so far that transplantation would essentially be futile.6PubMed Central. What Disqualifies You From a Liver Transplant?
The difficulty is that this boundary is not clean. Patients in the intensive care unit on life support occasionally do recover enough function after transplant, and predicting who will and who will not is still more art than science. This remains one of the hardest decisions in transplant medicine, and it is one of the areas where center-to-center variation is most pronounced.
Active Infections
Active systemic infections can temporarily or permanently disqualify you from being listed for transplant.7PubMed Central. AASLD AST Practice Guideline on Adult Liver Transplantation: Candidate Evaluation – Section: Referral for Liver Transplantation The reasoning is straightforward: after transplant, you will be placed on immunosuppressive drugs for life to prevent your body from rejecting the new organ. Performing major surgery and then suppressing the immune system in someone with an active infection is a recipe for overwhelming sepsis.
In most cases, this is a temporary hold rather than a permanent rejection. If the infection is identified and treated successfully, the evaluation can resume. Chronic infections like HIV and hepatitis B, which used to be absolute contraindications, are now manageable in many cases. Modern antiviral therapy means that HIV-positive patients with well-controlled viral loads and adequate immune function can be successful transplant recipients. Hepatitis C, once a leading cause of transplant and a feared cause of graft reinfection, has been transformed by direct-acting antiviral drugs. The infection itself is no longer a barrier.
Alcohol, Drugs, and the Changing Rules on Substance Use
Substance use disorder is one of the most contentious areas of transplant eligibility. For decades, most transplant programs imposed a strict six-month abstinence rule for patients with alcohol-related liver disease: you had to prove you had been sober for at least six months before you could be listed. This rule effectively made severe alcoholic hepatitis a death sentence for many, since the condition often kills within weeks to months and waiting six months was not a realistic option.8Journal of Hepatology. Liver transplantation for alcoholic hepatitis
That paradigm has shifted. A landmark European pilot study showed that carefully selected patients with severe alcoholic hepatitis who were not responding to medical therapy could achieve good outcomes with transplant, even without six months of sobriety. Subsequent studies in the United States corroborated those findings, and the strict six-month rule has loosened at many programs.8Journal of Hepatology. Liver transplantation for alcoholic hepatitis The emphasis has moved toward a more individualized assessment: Do you have insight into your drinking? Is there a support system in place? Are you engaged in treatment for the underlying addiction? These questions now weigh more heavily than a simple calendar count. That said, not all centers have adopted this approach, and inadequate remission duration from alcohol use remains one of the top reasons hospitalized patients are denied.9Liver Transplantation. National survey of second opinions for hospitalized patients in need of liver transplantation
Cannabis is another area where policy is evolving. Historically, some centers treated marijuana use as a disqualifier. But surveys of transplant professionals show that most now consider cannabis use rarely or never a contraindication.10PubMed Central. Assessment of Canadian policies regarding liver transplant candidacy of people who use alcohol, tobacco, cannabis, and opiates Despite this, data from real evaluations tell a different story: cannabis users have been significantly less likely to be listed for transplant even after adjusting for other factors, with roughly a 20% lower rate of being listed compared to nonusers.11PubMed Central. Cannabis and Liver Transplant in the Era of Legalization: Effects of Pre-Transplant Cannabis Use on Postoperative Opioid Use and Transplant Outcomes Whether this reflects lingering bias, legitimate concerns about adherence, or confounding factors is still being sorted out.
Psychosocial Evaluation and Medication Adherence
Every transplant program evaluates your psychological state, social support, and likely ability to follow the demanding post-transplant medication regimen. This is not a formality. A study comparing survival outcomes found that patients rated as having optimal psychosocial scores had post-transplant survival of about 85%, compared with roughly 56% in those with non-optimal scores.12PubMed. Pre-liver transplant psychosocial evaluation predicts post-transplantation outcomes After transplant, you must take immunosuppressive medications on schedule for the rest of your life. Missing doses or stopping medications can lead to organ rejection and graft loss. A documented history of habitual non-adherence with medical treatment is considered a contraindication, especially when someone is being evaluated for re-transplantation after losing a previous graft.13PubMed Central. Medical adherence and liver transplantation: a brief review
The psychosocial assessment covers several dimensions: current and past psychiatric disorders, substance use history, cognitive function, your ability to give informed consent, and the availability of a reliable caregiver or support network.14Journal of Clinical and Experimental Hepatology. Liver Transplant—Psychiatric and Psychosocial Aspects Lack of social support is, in fact, the single most common reason hospitalized patients are denied transplant, edging out even physical frailty.9Liver Transplantation. National survey of second opinions for hospitalized patients in need of liver transplantation This raises uncomfortable questions about fairness: patients who are socially isolated, homeless, or without family may be denied a life-saving treatment not because of a medical problem, but because of their social circumstances. Researchers studying the lived experiences of transplant candidates have described how the eligibility process creates a cultural logic of “worthy” and “unworthy” patients that can penalize people for factors largely outside their control.15PubMed Central. The chosen and the unchosen: How eligibility for liver transplant influences the lived experiences of patients with advanced liver disease
Physical Frailty and Functional Fitness
Your physical conditioning matters more than many people realize. Frailty has emerged as a powerful predictor of how patients with cirrhosis fare on the transplant waitlist and after surgery. Measures like grip strength, walking speed, and the ability to rise from a chair feed into frailty scores that transplant teams use to gauge surgical risk. Worsening frailty while on the waitlist is associated with roughly double the risk of death or being delisted due to becoming too sick.16PubMed Central. Changes in frailty are associated with waitlist mortality in patients with cirrhosis Sarcopenia, the loss of skeletal muscle mass that is common in advanced liver disease, is itself an independent risk factor for dying on the waitlist and for poor outcomes after transplant.17PubMed Central. Evaluating the Associations Between the Liver Frailty Index and Karnofsky Performance Status With Waitlist Mortality
However, an expert consensus statement from the American Society of Transplantation explicitly recommends that frailty should not be used as the sole criterion for removing someone from the transplant list. It should be considered alongside other factors when evaluating candidacy.18PubMed Central. Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice In practice, this means that if you are frail but otherwise a good candidate, the team may try to build you up with a structured prehabilitation program — physical therapy, nutritional support, and sometimes hormone optimization — rather than simply turning you away.
Obesity and BMI Thresholds
Severe obesity increases surgical risk. The technical challenges of operating on a patient with a very high BMI are real: more difficult surgical access, longer operative times, higher wound complication rates, and greater anesthesia risk. Some transplant centers set BMI cutoffs, commonly around 40, above which they will not list patients. But setting strict BMI cutoffs remains controversial, and the data supporting any particular threshold are limited.19PubMed Central. Liver Transplantation in the Obese Cirrhotic Patient
A large analysis of transplant recipients with class III obesity (BMI of 40 or above) found that their patient and graft survival were comparable to those of recipients with lower BMIs, with no significant difference detected over follow-up periods extending to ten years.20PubMed Central. Liver Transplantation in Recipients With Class III Obesity: Posttransplant Outcomes and Weight Gain This suggests that BMI-based exclusions may be overly blunt. Many centers now take a more individualized approach, considering body composition (how much is muscle versus fat), the distribution of fat, and whether weight loss before transplant is feasible. If you are told your BMI is too high, you may be given a target to reach before being reconsidered rather than being permanently rejected.
Age and Physiologic Reserve
There is no hard age cutoff for liver transplantation, though the practical reality is that advancing age narrows the window. Research on elderly recipients (typically defined as 60 and older) shows that age itself is less important than physiologic condition. Older patients who had relatively preserved liver function before transplant fared similarly to younger patients. But older patients who arrived sicker — with high bilirubin, poor synthetic function, or already hospitalized — had much worse outcomes than younger patients in the same condition.21PubMed Central. The Elderly Liver Transplant Recipient: A Call for Caution In other words, aging reduces your ability to tolerate the stress of surgery and recovery, and the further your other organs have declined, the greater the risk.
Most programs evaluate older candidates with extra scrutiny of cardiac function, kidney reserve, and bone density, and they weigh comorbidities more heavily. A 70-year-old with no other health problems and good functional status might be accepted. A 65-year-old with diabetes, coronary artery disease, and kidney impairment may not. Age is a relative contraindication that functions as a magnifying glass for everything else.
Anatomical and Vascular Complications
Certain anatomical abnormalities make transplant surgery technically difficult or impossible. The most significant is extensive portal vein thrombosis, where blood clots block the main vein carrying blood from the intestines to the liver. Liver transplantation in patients with cirrhosis and diffuse portomesenteric thrombosis is controversial and considered a contraindication at many centers because the surgeon may not have a usable vessel to connect the new liver’s blood supply.22Annals of Surgery. Multivisceral Transplantation for Diffuse Portomesenteric Thrombosis Some specialized centers have developed creative workarounds, including multivisceral transplant (replacing the liver along with portions of the intestine and its blood supply) and techniques adapted from living-donor surgery.23PubMed Central. A review of current status of living donor liver transplantation These procedures are performed at only a handful of high-volume programs, so what counts as an anatomical disqualifier depends heavily on where you are evaluated.
Why the Center You Go To Matters
One of the least understood aspects of transplant eligibility is how much it varies from program to program. Transplant centers in the United States set their own criteria on top of the basic medical guidelines. There is no nationally standardized evaluation process, and when surveyed, transplant programs were divided: about 38% favored standardizing evaluations, 39% opposed it, and about a quarter were unsure.9Liver Transplantation. National survey of second opinions for hospitalized patients in need of liver transplantation Center-specific criteria mean that a patient rejected at one center for medical, surgical, or psychosocial reasons may be an acceptable candidate at another.24PubMed. Rethinking Second Chances: When Rejected Liver Transplant Candidates Seek Reevaluation Elsewhere
Second opinions are common. About a quarter of transplant programs reported frequently facilitating second opinions for declined inpatients, and over half said they do so at least sometimes. Every program surveyed reported receiving referrals for second opinions, and roughly a quarter reported transplanting those referred patients more than 20% of the time.9Liver Transplantation. National survey of second opinions for hospitalized patients in need of liver transplantation If you are turned down, it is worth understanding why and asking whether the decision might differ elsewhere. Formal appeal processes exist at only about 25% of liver transplant centers, while about half have an informal process and the remaining quarter have none at all.25PubMed Central. Process Variation in Liver, Kidney, and Pancreas Transplantation: A Multicenter Evaluation From the Consortium for the Holistic Assessment of Risk in Transplant – Section: Post Committee Decisions Communication and Appeals
Socioeconomic Barriers That Work Like Disqualifiers
Formally, inability to pay is not a listed contraindication. In practice, financial and social factors heavily influence who gets evaluated, listed, and transplanted. Research has shown that patients are less likely to undergo evaluation, waitlisting, and transplant if they are women, Black, or lack commercial insurance.26PubMed Central. Sociodemographic differences in early access to liver transplantation services These disparities appear at every stage of the process, from referral to listing to actual surgery.
After transplant, the financial demands continue. Immunosuppressive medications are expensive, and about 17% of transplant recipients in one study reported medication trade-offs such as being unable to afford a prescription or choosing between medication and food. Insurance type, limited health literacy, and having multiple other medical conditions all raised the risk of these trade-offs.27PubMed. The prevalence, risk factors, and outcomes of medication trade-offs in kidney and liver transplant recipients: a pilot study Transplant teams know this, and they factor in your ability to afford and access long-term care when deciding whether to list you. The reasoning is that listing someone who cannot sustain lifelong immunosuppression wastes a scarce organ, but the effect is that poverty and lack of insurance function as de facto disqualifiers for some patients.
When Refusal of Blood Products Complicates Surgery
Liver transplant surgery involves substantial blood loss, and most patients receive transfusions during the procedure. Patients who refuse blood products on religious grounds, particularly Jehovah’s Witnesses, have historically been excluded from liver transplantation because of this risk.28PubMed Central. Live Donor Liver Transplantation Without Blood Products However, not all centers view refusal of transfusion as an absolute exclusion. Cases of successful transplantation in Jehovah’s Witness patients have been published since the 1980s, using aggressive blood conservation techniques and, in some cases, living-donor grafts that allow more controlled surgical conditions.29PubMed. Transfusion contracts for Jehovah’s Witnesses receiving organ transplants: ethical necessity or coercive pact? This is another area where your outcome depends heavily on which program you approach and their experience with bloodless surgery protocols.
Living Donors and the Expanding Frontier
Living-donor liver transplant is increasingly being used to push past traditional eligibility boundaries. Because a living donor offers a planned, elective surgery with a high-quality graft, the procedure can be offered to patients who might not fare well on the standard deceased-donor waitlist. Potential expansion areas include using living-donor grafts for patients with HCC beyond Milan criteria, certain bile duct cancers, and even colorectal cancer metastases confined to the liver.30PubMed. Future of U.S. living donor liver transplant: Donor and recipient criteria, transplant indications, transplant oncology, liver paired exchange, and non-directed donor graft allocation Older recipients, who may struggle with the long wait for a deceased-donor organ, are another group being considered for expanded living-donor access to allow transplant before their condition deteriorates further.
Living-donor surgery also opens doors for anatomical challenges. Conditions like extensive portal vein thrombosis and Budd-Chiari syndrome, which were previously considered contraindications to living-donor transplant, are now being tackled at specialized centers.23PubMed Central. A review of current status of living donor liver transplantation The availability of a willing, compatible living donor does not erase medical contraindications, but it meaningfully shifts the calculus for patients who sit in the gray zone between eligible and ineligible.